Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
INDIANAPOLIS, July 10, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, is pleased to announce that a team of scientists from the Center of PhenoGenomics at the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland was the recipient of the inaugural Harlan Best Communications Award. The award recognizes the best scientific paper presented during the Federation of European Laboratory Animal Science Associations (FELASA) International Congress.
The team from EPFL received the award for their research study that aimed to measure the impact of fenbendazole on cognitive and metabolic functions in mice. While fenbendazole is a common treatment for rodents contaminated with gastrointestinal parasites such as pinworms, not much is known of its side effects and how they impact experimental data from rodents that underwent such treatment. The study ultimately concluded that fenbendazole could be a recommended course of treatment for mice with pinworms, as it doesn’t seem to produce any major side effects on their neurobiological and metabolic functions.
“The novel research being conducted by the team of scientists at the Ecole Polytechnique Federale de Lausanne will help advance laboratory animal health and subsequently improve quality of research results,” said a company spokesman at Harlan Laboratories. “We are happy to present the inaugural Harlan Best Communications Award to such deserving recipients.”
Titled, “Impact of Fenbendazole on Neurobiologic Functions in Mice” the study was selected from over 300 submissions.
Harlan Laboratories also announced that due to the success of the inaugural award program, the company will continue its sponsorship of the award for the 13th FELASA Congress, which will be held in Bruxelles, Belgium in 2016. The winning entrant will be awarded with 5,000.
Experts from Harlan Laboratories also gave several presentations during the 2013 FELASA Congress, including scientific posters and speaking sessions. Hilton Klein, VMD, retired VP Regulatory, Science and Innovation at Harlan Laboratories, presented “Continuous Improvement of Quality in Animal Care and Use Programs: Strategies for Optimizing Animal Welfare and Research Using Quality Improvement Techniques with Performance Standards.” In addition, Harlan team members gave poster presentations titled, “The Effects of Transportation on Physiology and Behavior of Rats” and “Humane Endpoints in Aging Rodents.”
For more information on Harlan Laboratories or the Harlan Communications Award, visit www.harlan.com.
About Harlan Laboratories, Inc.
Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. Harlan Laboratories is a privately held company.
PRESS CONTACT:
Michael Clark
Miller Brooks, Inc.
317.873.8100
michael@millerbrooks.com
SOURCE Harlan Laboratories, Inc.
Help employers find you! Check out all the jobs and post your resume.
